These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11890661)

  • 1. Oncostatin M in the anti-inflammatory response.
    Wahl AF; Wallace PM
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii75-80. PubMed ID: 11890661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of inflammatory responses by oncostatin M.
    Wallace PM; MacMaster JF; Rouleau KA; Brown TJ; Loy JK; Donaldson KL; Wahl AF
    J Immunol; 1999 May; 162(9):5547-55. PubMed ID: 10228036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M: development of a pleiotropic cytokine.
    Loy JK; Davidson TJ; Berry KK; Macmaster JF; Danle B; Durham SK
    Toxicol Pathol; 1999; 27(2):151-5. PubMed ID: 10207978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL.
    Hui W; Cawston TE; Richards CD; Rowan AD
    Arthritis Res Ther; 2005; 7(1):R57-64. PubMed ID: 15642143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease.
    Bamber B; Reife RA; Haugen HS; Clegg CH
    J Mol Med (Berl); 1998 Jan; 76(1):61-9. PubMed ID: 9462869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation.
    Fonseca LC; Dadarkar SS; Lobo AS; Suthar AC; Chauhan VS; Chandrababu S; Sharma SD; Dagia NM; Padigaru M
    Eur J Pharmacol; 2010 Oct; 644(1-3):220-9. PubMed ID: 20621086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.
    Modur V; Feldhaus MJ; Weyrich AS; Jicha DL; Prescott SM; Zimmerman GA; McIntyre TM
    J Clin Invest; 1997 Jul; 100(1):158-68. PubMed ID: 9202068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
    Repovic P; Mi K; Benveniste EN
    Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
    Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
    J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M, but not interleukin-6 or leukemia inhibitory factor, stimulates expression of alpha1-proteinase inhibitor in A549 human alveolar epithelial cells.
    Sallenave JM; Tremblay GM; Gauldie J; Richards CD
    J Interferon Cytokine Res; 1997 Jun; 17(6):337-46. PubMed ID: 9198001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M, a multifunctional cytokine.
    Tanaka M; Miyajima A
    Rev Physiol Biochem Pharmacol; 2003; 149():39-52. PubMed ID: 12811586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice.
    Liu L; Xiong H; Ping J; Ju Y; Zhang X
    J Ethnopharmacol; 2010 Jul; 130(2):392-7. PubMed ID: 20510343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of oncostatin M in human plasma and serum by a sensitive enzyme immunoassay.
    Naemura JR; Radka SF
    Lymphokine Cytokine Res; 1993 Jun; 12(3):187-90. PubMed ID: 8347766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of glycosaminoglycan derived from Gryllus bimaculatus (a type of cricket, insect) on adjuvant-treated chronic arthritis rat model.
    Ahn MY; Han JW; Hwang JS; Yun EY; Lee BM
    J Toxicol Environ Health A; 2014; 77(22-24):1332-45. PubMed ID: 25343284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation.
    Podolin PL; Callahan JF; Bolognese BJ; Li YH; Carlson K; Davis TG; Mellor GW; Evans C; Roshak AK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):373-81. PubMed ID: 15316093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds.
    Goren I; Kämpfer H; Müller E; Schiefelbein D; Pfeilschifter J; Frank S
    J Invest Dermatol; 2006 Mar; 126(3):628-37. PubMed ID: 16410783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo anti-inflammatory activities of Polygonum hydropiper methanol extract.
    Yang Y; Yu T; Jang HJ; Byeon SE; Song SY; Lee BH; Rhee MH; Kim TW; Lee J; Hong S; Cho JY
    J Ethnopharmacol; 2012 Jan; 139(2):616-25. PubMed ID: 22182430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors.
    Strålberg F; Kassem A; Kasprzykowski F; Abrahamson M; Grubb A; Lindholm C; Lerner UH
    J Leukoc Biol; 2017 May; 101(5):1233-1243. PubMed ID: 28196851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.